EUVIMEDEUVIMED entdecken
Crossref

A Story of Serendipities: From Phlorizin to Gliflozins

Özant Helvacı, Burçak Helvacı

Experimental and Clinical Transplantation · 2023-06 · 21 (Suppl 2) · 105-108

DOI: 10.6002/ect.iahncongress.25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental and Clinical Transplantation, 2023-06. Verfasst von Özant Helvacı und 1 weiteren Autor:innen. Beteiligte Einrichtung: From the Gazi University Faculty of Medicine, Department of Nephrology, Ankara, Turkey. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sodium-Glucose Transporter 2 InhibitorsDiabetes Mellitus, Type 2AnimalsDogsPhlorhizinHypoglycemic AgentsInsulin

Substanzen

Sodium-Glucose Transporter 2 InhibitorsPhlorhizinHypoglycemic AgentsInsulin

Autor:innen und Institutionen

  • From the Gazi University Faculty of Medicine, Department of Nephrology, Ankara, Turkey.

Zitieren

APA

Helvacı, Ö., & Helvacı, B. (2023). A Story of Serendipities: From Phlorizin to Gliflozins. Experimental and Clinical Transplantation, 21(Suppl 2), 105-108. https://doi.org/10.6002/ect.iahncongress.25

Vancouver

Helvacı Ö, Helvacı B. A Story of Serendipities: From Phlorizin to Gliflozins. Experimental and Clinical Transplantation. 2023;21(Suppl 2):105-108. doi:10.6002/ect.iahncongress.25

BibTeX
@article{Helvac2023,
  author = {Helvacı, Özant and Helvacı, Burçak},
  title = {A Story of Serendipities: From Phlorizin to Gliflozins},
  journal = {Experimental and Clinical Transplantation},
  year = {2023},
  volume = {21},
  number = {Suppl 2},
  pages = {105--108},
  doi = {10.6002/ect.iahncongress.25}
}
Kostenlos starten →